Thurston Springer Miller Herd & Titak’s Idexx Laboratories IDXX Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.89K	Hold	15	–	–	﹤0.01%	893
2026 Q1	$8.43K	Sell	15 -10	-40%	-$6.41K	﹤0.01%	943
2025 Q4	$16.9K	Buy	+25	New	+$17K	0.01%	796
2025 Q3	–	Sell	-20	Closed	-$10.7K	–	930
2025 Q2	$10.7K	Hold	20	–	–	﹤0.01%	1128
2025 Q1	$8.4K	Buy	20 +10	+100%	+$4.34K	﹤0.01%	1166
2024 Q4	$4.13K	Hold	10	–	–	﹤0.01%	1051
2024 Q3	$5.05K	Sell	10 -17	-63%	-$8.26K	﹤0.01%	1191
2024 Q2	$13.2K	Buy	+27	New	+$13.6K	﹤0.01%	924

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's IDXX Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 15 shares worth $7.89K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Thurston Springer Miller Herd & Titak first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.9K in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Thurston Springer Miller Herd & Titak held 15 shares of Idexx Laboratories worth $7.89K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #893 holding.
Thurston Springer Miller Herd & Titak first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's Idexx Laboratories position peaked at $16.9K in Q4 2025.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.